0000950170-24-025027.txt : 20240304
0000950170-24-025027.hdr.sgml : 20240304
20240304174524
ACCESSION NUMBER: 0000950170-24-025027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chang David J.
CENTRAL INDEX KEY: 0001790552
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39103
FILM NUMBER: 24716649
MAIL ADDRESS:
STREET 1: C/O CABALETTA BIO, INC.
STREET 2: 2929 ARCH STREET, SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cabaletta Bio, Inc.
CENTRAL INDEX KEY: 0001759138
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (267) 759-3100
MAIL ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
ownership.xml
4
X0508
4
2024-03-01
0001759138
Cabaletta Bio, Inc.
CABA
0001790552
Chang David J.
C/O CABALETTA BIO, INC.
2929 ARCH STREET, SUITE 600
PHILADELPHIA
PA
19104
false
true
false
false
Chief Medical Officer
false
Stock Option (Right to Buy)
23.97
2024-03-01
4
A
false
130000
0.00
A
2034-02-28
Common Stock
130000
130000
D
25% of the shares underlying this option shall vest and become exercisable on March 1, 2025, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.
By: /s/ Michael Gerard, as Attorney-in-Fact
2024-03-04